常用升白细胞药物在肿瘤治疗中的应用进展

发布时间：2019-01-05 07:08

【摘要】：目的:为升白细胞药物的深入研究和合理应用提供理论依据。方法:收集近年来国内、外相关研究文献进行归纳和综述。结果与结论:利可君、维生素B4、鲨肝醇等传统药物用于发生Ⅰ、Ⅱ度白细胞减少症的患者,疗程虽长,但仍能恢复至正常水平;而对于发生Ⅲ、Ⅳ度白细胞减少症的患者,有效率较低。近年来出现的多种刺激因子(如粒细胞集落刺激因子)用于重度白细胞减少症有更好的疗效,有利于大量强化治疗,缩短应用肿瘤放化疗周期,减少感染等并发症,但其长期使用的安全性需要进一步关注与监测。
[Abstract]:Objective: to provide theoretical basis for further study and rational application of leukocyte-raising drugs. Methods: domestic and foreign literatures were collected and summarized in recent years. Results & conclusion: the traditional drugs such as rikejun, vitamin B4 and shark liver alcohol were used in the patients with grade 鈪，

本文编号：2401457